Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis

N. Kennedy, S. H. Gillespie*, A. O S Saruni, G. Kisyombe, R. Mc Nerney, F. I. Ngowi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

72 Citations (Scopus)

Abstract

The use of the polymerase chain reaction (PCR) for assessing treatment response in tuberculosis was investigated. Serial sputum samples were analyzed from 10 Tanzanian patients treated for smear-positive pulmonary tuberculosis, including 4 who relapsed after initially successful treatment. A one-tube nested PCR with a colorimetric detection system was compared with microscopy and culture. Samples were found to be negative by microscopy before they were by PCR or culture, often remaining positive 1-2 months longer by PCR than by culture. For the 76 samples available for both culture and peR, there was a 76% (58/76) agreement between the methods. Nine samples were negative by culture but positive by PCR; 7 were either negative (5) or equivocal (2) by peR despite being positive by culture. Two of the 4 relapse cases were detected earlier by PCR than by culture. These results demonstrate that PCR is a promising method for assessing treatment response in pulmonary tuberculosis.

Original languageEnglish
Pages (from-to)713-716
Number of pages4
JournalJournal of Infectious Diseases
Volume170
Issue number3
DOIs
Publication statusPublished - 1 Jan 1994

Fingerprint

Dive into the research topics of 'Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis'. Together they form a unique fingerprint.

Cite this